|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/5513 | |
| A61K 31/355 | |||
| A61K 47/10 | |||
| A61K 9/00 |
| (11) | Number of the document | 2271347 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09723906.5 |
| Date of filing the European patent application | 2009-03-27 | |
| (97) | Date of publication of the European application | 2011-01-12 |
| (45) | Date of publication and mention of the grant of the patent | 2016-05-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/038696 |
| Date | 2009-03-27 |
| (87) | Number | WO 2009/121039 |
| Date | 2009-10-01 |
| (30) | Number | Date | Country code |
| 40558 | 2008-03-28 | US |
| (72) |
CARTT, Steve, US
MEDEIROS, David, US
GWOZDZ, Garry, Thomas, US
LOXLEY, Andrew, US
MITCHNICK, Mark, US
HALE, David, US
|
| (73) |
Hale BioPharma Ventures, LLC,
1042-B N. El Camino Real Suite 430, Encinitas, CA 92024,
US
|
| (54) | ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS |
| ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS |